Polypille in der Sekundärprävention des Herzinfarktes-Reference-Cited by-同舟云学术

Polypille in der Sekundärprävention des Herzinfarktes

Published:2017-09-20 Issue:6 Volume:11 Page:473-479
ISSN:1864-9718
Container-title:Der Kardiologe
language:de
Short-container-title:Kardiologe

Author:

Barth C.,Diekmann S.,Neusser S.,Bramlage P.,Wasem J.,Neumann A.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s12181-017-0195-4/fulltext.html

Reference31 articles.

1. Bach JP, Riedel O, Pieper L et al (2011) Health-related quality of life in patients with a history of myocardial infarction and stroke. Cerebrovasc Dis 31:68–76

2. Barrios V, Kaskens L, Castellano JM et al (2017) Usefulness of a cardiovascular polypill in the treatment of secondary prevention patients in Spain: a cost-effectiveness study. Rev Esp Cardiol (Engl Ed) 70:42–49

3. Becerra V, Gracia A, Desai K et al (2015) Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. BMJ Open 5:e7111

4. Bock JO, Brettschneider C, Seidl H et al (2015) Calculation of standardised unit costs from a societal perspective for health economic evaluation. Gesundheitswesen 77:53–61

5. Bramlage P, Sims H, Minguet J et al (2017) The polypill: an effective approach to increasing adherence and reducing cardiovascular event risk. Eur J Prev Cardiol 24:297–310

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review;PLOS ONE;2022-07-28

2. Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness;PharmacoEconomics;2020-06-25